Does Mammotome biopsy affect surgery option and margin status of breast conserving surgery in breast cancer? | Zendy

Yanan Kong | Zendy; Ning Lyu | Zendy; Jianwei Wang | Zendy; Yan Wang | Zendy; Ya Sun | Zendy; Zeming Xie | Zendy; Peng Liu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Mammotome biopsy affect surgery option and margin status of breast conserving surgery in breast cancer?

Author(s) -

Yanan Kong,

Ning Lyu,

Jianwei Wang,

Yan Wang,

Ya Sun,

Zeming Xie,

Peng Liu

Publication year - 2021

Publication title -

gland surgery

Language(s) - English

Resource type - Journals

eISSN - 2227-8575

pISSN - 2227-684X

DOI - 10.21037/gs-20-701

Subject(s) - mammotome , medicine , breast conserving surgery , hematoma , breast cancer , biopsy , mastectomy , breast biopsy , surgery , breast surgery , radiology , cancer , mammography

The Mammotome, an image-guided, usually ultrasound-guided vacuum-assisted breast biopsy (US-VABB) system, has been widely used in the early diagnosis of breast disease and the complete excision of benign lesions. However, in some malignant lesions underestimated by U.S., whether Mammotome biopsy would affect the surgery option, especially the margin status in breast-conserving surgery (BCS), has never been studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research